216 related articles for article (PubMed ID: 11245645)
1. Polycystic ovary syndrome is associated with endothelial dysfunction.
Paradisi G; Steinberg HO; Hempfling A; Cronin J; Hook G; Shepard MK; Baron AD
Circulation; 2001 Mar; 103(10):1410-5. PubMed ID: 11245645
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
Paradisi G; Steinberg HO; Shepard MK; Hook G; Baron AD
J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
[TBL] [Abstract][Full Text] [Related]
3. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
Steinberg HO; Chaker H; Leaming R; Johnson A; Brechtel G; Baron AD
J Clin Invest; 1996 Jun; 97(11):2601-10. PubMed ID: 8647954
[TBL] [Abstract][Full Text] [Related]
4. Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.
Usselman CW; Yarovinsky TO; Steele FE; Leone CA; Taylor HS; Bender JR; Stachenfeld NS
J Physiol; 2019 Jun; 597(11):2853-2865. PubMed ID: 30847930
[TBL] [Abstract][Full Text] [Related]
5. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
[TBL] [Abstract][Full Text] [Related]
6. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
[TBL] [Abstract][Full Text] [Related]
7. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
Kravariti M; Naka KK; Kalantaridou SN; Kazakos N; Katsouras CS; Makrigiannakis A; Paraskevaidis EA; Chrousos GP; Tsatsoulis A; Michalis LK
J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
[TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation.
Tarkun I; Arslan BC; Cantürk Z; Türemen E; Sahin T; Duman C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5592-6. PubMed ID: 15531516
[TBL] [Abstract][Full Text] [Related]
9. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.
Mather KJ; Verma S; Corenblum B; Anderson TJ
J Clin Endocrinol Metab; 2000 May; 85(5):1851-6. PubMed ID: 10843164
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans.
Steinberg HO; Bayazeed B; Hook G; Johnson A; Cronin J; Baron AD
Circulation; 1997 Nov; 96(10):3287-93. PubMed ID: 9396418
[TBL] [Abstract][Full Text] [Related]
11. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.
Pepene CE; Ilie IR; Marian I; Duncea I
Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.
Arikan S; Akay H; Bahceci M; Tuzcu A; Gokalp D
Fertil Steril; 2009 Feb; 91(2):450-5. PubMed ID: 18501898
[TBL] [Abstract][Full Text] [Related]
14. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.
Sorensen MB; Franks S; Robertson C; Pennell DJ; Collins P
Clin Endocrinol (Oxf); 2006 Nov; 65(5):655-9. PubMed ID: 17054469
[TBL] [Abstract][Full Text] [Related]
15. Vascular dysfunction and metabolic parameters in polycystic ovary syndrome.
Meyer C; McGrath BP; Cameron J; Kotsopoulos D; Teede HJ
J Clin Endocrinol Metab; 2005 Aug; 90(8):4630-5. PubMed ID: 15870132
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
[TBL] [Abstract][Full Text] [Related]
17. Type II diabetes abrogates sex differences in endothelial function in premenopausal women.
Steinberg HO; Paradisi G; Cronin J; Crowde K; Hempfling A; Hook G; Baron AD
Circulation; 2000 May; 101(17):2040-6. PubMed ID: 10790344
[TBL] [Abstract][Full Text] [Related]
18. Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS).
Hurliman A; Keller Brown J; Maille N; Mandala M; Casson P; Osol G
Endocrinology; 2015 Nov; 156(11):4071-80. PubMed ID: 26322372
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition.
Sprung VS; Jones H; Pugh CJ; Aziz NF; Daousi C; Kemp GJ; Green DJ; Cable NT; Cuthbertson DJ
Clin Sci (Lond); 2014 Jan; 126(1):67-74. PubMed ID: 23826984
[TBL] [Abstract][Full Text] [Related]
20. The effects of laparoscopic ovarian drilling on flow mediated dilation in women with PCOS: relationship with insulin resistance and IGF-I.
Shokeir T; El-Kannishy G
Minerva Ginecol; 2014 Apr; 66(2):209-18. PubMed ID: 24848079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
